Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02756767 · ClinicalTrials.gov registry record
Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 75
- Enrollment target
NCT02756767: Completed study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT02756767 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02756767 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
The goals of this study are to assess the feasibility of weekly administration of site specific patient reported assessments using an electronic platform and to explore the correlation between patient reported outcomes as well as known dosimetric prognostic factors in patients with lung, breast, head and neck, or pelvic malignancies
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-04 |
| Est. Completion | 2021-04 |
What the finished NCT02756767 record still lists
NCT02756767 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT02756767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02756767 about?
NCT02756767 is a clinical study titled "Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology". The goals of this study are to assess the feasibility of weekly administration of site specific patient reported assessments using an electronic platform and to explore the correlation between patient reported outcomes as well as known dosimetric prognostic factors in patients with lung, breast, hea...
What is the current status of trial NCT02756767?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2016-04. Estimated completion is 2021-04.
What interventions are being tested in trial NCT02756767?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT02756767?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia